These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16603132)

  • 1. Dopaminergic modulation of semantic priming in healthy volunteers.
    Roesch-Ely D; Weiland S; Scheffel H; Schwaninger M; Hundemer HP; Kolter T; Weisbrod M
    Biol Psychiatry; 2006 Sep; 60(6):604-11. PubMed ID: 16603132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of dopamine on semantic activation in Parkinson's disease: evidence from a multipriming task.
    Angwin AJ; Copland DA; Chenery HJ; Murdoch BE; Silburn PA
    Neuropsychology; 2006 May; 20(3):299-306. PubMed ID: 16719623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functional magnetic resonance imaging study of the effects of pergolide, a dopamine receptor agonist, on component processes of working memory.
    Gibbs SE; D'Esposito M
    Neuroscience; 2006 Apr; 139(1):359-71. PubMed ID: 16458442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine and semantic activation: an investigation of masked direct and indirect priming.
    Angwin AJ; Chenery HJ; Copland DA; Arnott WL; Murdoch BE; Silburn PA
    J Int Neuropsychol Soc; 2004 Jan; 10(1):15-25. PubMed ID: 14751003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of dopaminergic modulation of cognitive flexibility.
    Smyth SF; Beversdorf DQ
    Cogn Behav Neurol; 2007 Dec; 20(4):225-9. PubMed ID: 18091071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased temporal and prefrontal activity in response to semantic associations in schizophrenia.
    Kuperberg GR; Deckersbach T; Holt DJ; Goff D; West WC
    Arch Gen Psychiatry; 2007 Feb; 64(2):138-51. PubMed ID: 17283282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemispheric differences in strong versus weak semantic priming: evidence from event-related brain potentials.
    Frishkoff GA
    Brain Lang; 2007 Jan; 100(1):23-43. PubMed ID: 16908058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional MRI study of the effects of bromocriptine, a dopamine receptor agonist, on component processes of working memory.
    Gibbs SE; D'Esposito M
    Psychopharmacology (Berl); 2005 Aug; 180(4):644-53. PubMed ID: 16001111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic neuromodulation of semantic priming in a cortical network model.
    Lavigne F; Darmon N
    Neuropsychologia; 2008 Nov; 46(13):3074-87. PubMed ID: 18647615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summation of semantic priming and complex sentence comprehension in Parkinson's disease.
    Angwin AJ; Chenery HJ; Copland DA; Murdoch BE; Silburn PA
    Brain Res Cogn Brain Res; 2005 Sep; 25(1):78-89. PubMed ID: 15894470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic potentiation of rTMS-induced motor cortex inhibition.
    Lang N; Speck S; Harms J; Rothkegel H; Paulus W; Sommer M
    Biol Psychiatry; 2008 Jan; 63(2):231-3. PubMed ID: 17604004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users.
    Morgan CJ; Rossell SL; Pepper F; Smart J; Blackburn J; Brandner B; Curran HV
    Biol Psychiatry; 2006 Feb; 59(3):265-72. PubMed ID: 16140283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory.
    Costa A; Peppe A; Dell'Agnello G; Caltagirone C; Carlesimo GA
    Neuropsychologia; 2009 Apr; 47(5):1374-81. PubMed ID: 19428401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine, paranormal belief, and the detection of meaningful stimuli.
    Krummenacher P; Mohr C; Haker H; Brugger P
    J Cogn Neurosci; 2010 Aug; 22(8):1670-81. PubMed ID: 19642883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic neuromodulation of semantic processing: a 4-T FMRI study with levodopa.
    Copland DA; McMahon KL; Silburn PA; de Zubicaray GI
    Cereb Cortex; 2009 Nov; 19(11):2651-8. PubMed ID: 19321651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric schizotypy modulates levodopa effects on lateralized lexical decision performance.
    Mohr C; Krummenacher P; Landis T; Sandor PS; Fathi M; Brugger P
    J Psychiatr Res; 2005 May; 39(3):241-50. PubMed ID: 15725422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The speed of lexical activation is altered in Parkinson's disease.
    Angwin AJ; Chenery HJ; Copland DA; Murdoch BE; Silburn PA
    J Clin Exp Neuropsychol; 2007 Jan; 29(1):73-85. PubMed ID: 17162724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The basal ganglia and semantic engagement: potential insights from semantic priming in individuals with subcortical vascular lesions, Parkinson's disease, and cortical lesions.
    Copland D
    J Int Neuropsychol Soc; 2003 Nov; 9(7):1041-52. PubMed ID: 14738285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers.
    Mehta MA; Swainson R; Ogilvie AD; Sahakian J; Robbins TW
    Psychopharmacology (Berl); 2001 Dec; 159(1):10-20. PubMed ID: 11797064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of semantic processing abnormalities in schizotypy using an indirect semantic priming task.
    Johnston AE; Rossell SL; Gleeson JF
    J Nerv Ment Dis; 2008 Sep; 196(9):694-701. PubMed ID: 18791431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.